ArticleOncoimmunology

Triple combination immunotherapy with GVAX, anti-PD-1 monoclonal antibody, and agonist anti-OX40 monoclonal antibody is highly effective against murine intracranial glioma.

Nusrat Jahan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.